Roche Holding AG : The stock forcefully approaches new pivot levels
BUY
Conditionne
Stop-loss triggered
Entry price | Target | Stop-loss | Potential |
---|
CHF 253 |
CHF 270 |
CHF 242.2 |
+6.72% |
---|
Below the resistance zone that is currently being tested, the potential for new gains appears limited for shares in Roche Holding Ltd.. The stock's technical chart pattern suggests however that the level will be broken.
Summary● The company has solid fundamentals for a short-term investment strategy.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● This company will be of major interest to investors in search of a high dividend stock.
● Sales forecast by analysts have been recently revised upwards.
● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at CHF 252.2.
● Technically, the stock approaches a strong medium-term resistance at CHF 251.65.
● According to forecast, a sluggish sales growth is expected for the next fiscal years.
● The group usually releases earnings worse than estimated.
● The company's enterprise value to sales, at 3.85 times its current sales, is high.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.